A cost-effective interdisciplinary approach to microbiologic send-out test use

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 2, 2015, Pages 194-198

  Aesif, Scott W ^a   Parenti, David M ^a   Lesky, Linda ^a   Keiser, John F ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; FINANCIAL MANAGEMENT; HOSPITAL DEPARTMENT; HOSPITAL LABORATORY; HUMAN; LABORATORY DIAGNOSIS; MICROBIOLOGICAL EXAMINATION; ORGANIZATION; PATIENT REFERRAL; PHYSICIAN; STANDARDS; UNITED STATES; UTILIZATION; UTILIZATION REVIEW;

CLINICAL LABORATORY SERVICES; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; HUMANS; LABORATORIES, HOSPITAL; MICROBIOLOGICAL TECHNIQUES; OUTSOURCED SERVICES; PATHOLOGY DEPARTMENT, HOSPITAL; PHYSICIANS; REFERRAL AND CONSULTATION; UNITED STATES; UTILIZATION REVIEW;

EID: 84921498169     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0693-OA     Document Type: Article

References (14)

1. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds.; National Research Council. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: National Academies Press; 2013.
2. Weinberger SE. Providing high-value, cost-conscious care: a critical seventh general competency for physicians. Ann Intern Med. 2011;155(6):386-388.
3. Tilburt JC, Wynia MK, Sheeler RD, et al. Views of US physicians about controlling health care costs. JAMA. 2013;310(4):380-388.
4. van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003;49(12):1997-2005.
5. Bates DW, Boyle DL, Rittenberg E, et al. What proportion of common diagnostic tests appear redundant? Am J Med. 1998;104(4):361-368.
6. Carter E, Bennett BD. Reference test review by pathology house staff: a cost-containment strategy for the clinical laboratory. Clin Leadersh Manag Rev. 2002;16(1):3-6.
7. Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012; 156(2):147-149.
8. Laine C. High-value testing begins with a few simple questions. Ann Intern Med. 2012;156(2):162-163.
9. Hawkins R. Managing the pre-and post-analytical phases of the total testing process. Ann Lab Med. 2012;32(1):5-16.
10. MacMillan D, Lewandrowski E, Lewandrowski K. An analysis of reference laboratory (send out) testing: an 8-year experience in a large academic medical center. Clin Leadersh Manag Rev. 2004;18(4):216-219.
11. Valenstein PN, Praestgaard AH, Lepoff RB. Six-year trends in productivity and utilization of 73 clinical laboratories: a College of American Pathologists laboratory management index program study. Arch Pathol Lab Med. 2001;125(9): 1153-1161.
12. Liu Z, Abdullah A, Baskin L, Lewis G, Kelter G, Naugler C. An intervention to reduce laboratory utilization of referred-out tests. Lab Med. 2012;43(5):164-167.
13. Zhao JJ, Liberman A. Pathologists' roles in clinical utilization management: a financing model for managed care. Am J Clin Pathol. 2000;113(3):336-342.
14. Warren JS. Laboratory test utilization program: structure and impact in a large academic medical center. Am J Clin Pathol. 2013;139(3):289-297.